March 11, 2020 / 6:09 PM / 19 days ago

BRIEF-Biosight Raises $19M In Series C Funding To Support Clinical Stage Oncology Programs

March 11 (Reuters) - BIOSIGHT:

* BIOSIGHT RAISES $19M IN SERIES C FUNDING TO SUPPORT CLINICAL STAGE ONCOLOGY PROGRAMS

* BIOSIGHT - INVESTMENT IS LED BY ISRAEL BIOTECH FUND WITH PARTICIPATION BY SBI JI INNOVATION FUND, ARKIN BIO VENTURES, AMONG OTHERS

* BIOSIGHT - NEW CAPITAL WILL ADVANCE CLINICAL DEVELOPMENT OF BIOSIGHT’S LEAD ASSET BST-236 (ASPACYTARABINE) Source text:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below